Epidemiology of gonorrhoea-related hospitalisations in Spain between 1997 and 2006
The prevalence of gonorrhoea has increased worldwide in the last few years. Gonorrhoea is one of the most common sexually transmitted infections (STIs) in the world, and is a serious public health problem because of its associated morbidity and complications. The objective of this study was to estimate the frequency of gonorrhoea-related hospitalisations in Spain between the years 1997 and 2006.
A retrospective epidemiological study was conducted using data from the National Epidemiological Surveillance System (Minimum Data Set [MDS]), where all of the gonorrhoea-related hospitalisations that occurred in Spain during this period were analysed. We calculated the general hospitalisation rates, mortality, case-fatality rate, and length of stay by gender and age.
During the course of the study, 928 hospitalisations occurred with a discharge diagnosis of gonorrhoea infection (International Classification of Diseases, 9th Revision, Clinical Modification: ICD 9 CM 098.0-098.89 at any diagnostic position), which represented a hospitalisation rate of 0.23 per 100,000 population, a mortality rate of 0.008 per 100,000 population, and a case-fatality of 3.77%. The main suspected causes of death were staphylococcal and streptococcal infections, malignant neoplasm and chronic diseases. The greatest hospitalisation rate was observed in children between the ages of 0 and 4years.
The gonorrhoea-related hospitalisation rate in Spain remained constant during the period of the study. A better understanding of the epidemiology of gonorrhoea will allow for the creation of effective preventive measures that will lead to a reduction in the number of new infections.
Available from: Anja Takla
[Show abstract] [Hide abstract]
ABSTRACT: In Germany, mumps has been notifiable until 2013 only in the five Eastern federal states (EFS) of former East Germany. Due to different immunisation policies until 1990 and varying vaccination coverages thereafter, mumps incidences cannot be extrapolated to the 11 Western federal states (WFS). We studied mumps-related International Classification of Diseases (ICD-10) code diagnoses claimed through statutory health insurances between 2007 and 2011 to estimate countrywide mumps incidences in the outpatient sector, and compared them with case numbers from ambulatory notification data. Overall, 32,330 outpatient mumps cases were claimed. Annual incidence ranged between 9.3/100,000 and 11.8/100,000 and showed a significant decreasing trend. Compared with EFS, mumps incidence in WFS was higher and indicated a shift towards older age groups. Notified outpatient case numbers in EFS were 13-fold lower and from voluntary surveillance during an outbreak in the WFS Bavaria 8-fold lower than from insurance data (n=316 versus n=4,217 and n=238 versus 1,995, respectively). Of all notified cases with available information, 75.4% (EFS) and 57.6% (Bavaria) were unvaccinated; 6.8% (EFS) and 19.3% (Bavaria) required hospitalisation. In Germany, mumps is still endemic despite decades of vaccination, with considerable underreporting in the established notification systems.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.